IP Library Granted Patent US 10,877,055
Granted Patent B2
US 10,877,055 · App. 16/245,924 · Granted Dec 29, 2020

Parallel cell processing method and facility

Inventors: Firman Ghouze (Singapore, SG); Philip Vanek (Ashburn, VA)
Assignee: Global Life Sciences Solutions USA LLC
G01N35/0099A61K35/12G01N35/00732B01J2219/00587B01J2219/00743G01N2035/00326G01N2035/00752G01N2035/00762G01N2035/00782G01N2035/00811G01N2035/00831
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,877,055
App. No.
16/245,924
Granted
Dec 29, 2020
Kind
B2
Abstract

The present invention provides improved methods, facilities and systems for parallel processing of biological cellular samples in an efficient and scalable manner. The invention enables parallel processing of biological cellular samples, such as patient samples, in a space and time efficient fashion. The methods, facilities and systems of the invention find particular utility in processing patient samples for use in cell therapy.

Claims (19)

1. A method for parallel processing of a plurality of biological cellular samples comprising:

i) transferring one of a plurality of cellular samples (S 1 to Sn) to a first processing unit (U 1 ) containing a single processing station (P 1 / 1 );

ii) processing said one of the cellular samples (S 1 to Sn) on the single processing station (P 1 / 1 ) to produce a processed cellular sample (S 1 / 1 );

iii) repeating steps i) and ii) and for further cellular samples (S 2 to Sn) of the plurality of cellular samples (S 1 to Sn) to produce a first plurality of processed cellular samples (S 1 / 1 to Sn/ 1 );

iv) transferring said first plurality of processed cellular samples (S 1 / 1 to Sn/ 1 ) to a second processing unit (U 2 ) containing a plurality of identical processing stations (P 2 / 1 to P 2 /n);

v) processing in parallel each of said first plurality of processed cellular samples (S 1 / 1 to Sn/ 1 ) on a processing station (P 2 / 1 to P 2 /n) to produce a second plurality of processed cellular samples (S 1 / 2 to Sn/ 2 ); and

vi) transferring said second plurality of processed cellular samples to one or more further processing units (UN) and further processing said second plurality of processed cellular samples in said further processing units (UN) to produce a third plurality of processed cellular samples (S 1 /N to Sn/N), wherein the processing of the cellular samples comprises cell transduction.

2. The method according to claim 1 , wherein each of said cellular samples (S 1 to Sn) is uniquely identifiable.

3. The method according to claim 1 , wherein each of the cellular samples (S 1 to Sn) is enclosed in container, which container is uniquely identifiable.

4. The method according to claim 1 , wherein each of the cellular samples comprise human cells.

5. The method according to claim 1 , wherein the cellular samples are selected from the group consisting of blood samples, tissue aspirates, tissue biopsies, bone marrow, adipose tissue and umbilical cord blood.

6. The method according to claim 1 , wherein the cellular samples are derived from one or more patients.

7. The method according to claim 1 , wherein the processing of the cellular samples further involves one or more processes selected from the group consisting of cell isolation, cell culture, cell expansion, and cell formulation.

8. The method according to claim 1 , additionally comprising the step of storing the third plurality of processed cellular samples (S 1 /N to Sn/N) in a cell bank.

9. The method according to claim 1 , wherein said method is an automated method.

10. The method according to claim 1 , additionally comprising the step of administering one or more of the third plurality of processed cellular samples (S 1 /N to Sn/N) to one or more patients.

11. The method according to claim 10 , wherein said one or more patients are the original donors of the cellular samples (S 1 to Sn).

12. The method according to claim 10 , wherein said one or more patients are not an original donor of the cellular sample (S 1 to Sn).

13. The method according to claim 10 , wherein said patient is a cancer patient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2020
From: GHOUZE, FIRMAN; VANEK, PHILIP
To: GE HEALTHCARE BIO-SCIENCES CORP.
Reel/Frame 054273/0672 →
CHANGE OF NAME Recorded Aug 31, 2020
From: GE HEALTHCARE BIO-SCIENCES CORP.
To: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
Reel/Frame 053648/0854 →
Priority Claims (1)
GB 1415329.0 · Aug 29, 2014 · national
Continuity (3)
Continuation 15327800
Provisional Application 62026748 · Jul 21, 2014
Related Publication 20190250179A1 · Aug 15, 2019